Euronext Lisbon welcomes Farminveste


Lisbon, 16 October 2018 – Euronext today welcomed Farminveste SGPA, SA (“Farminveste”) on  Euronext Access in Lisbon.

Farminveste is an investment company whose corporate objective is to invest in companies in the areas of pharmaceutical distribution, information technology and systems, pharmaceutical market intelligence, provision of healthcare services and real estate. Its main shareholder  is the Portuguese National Pharmacies Association whose membership comprises almost all pharmacies in Portugal. Other shareholders include several Portuguese Pharmacies.

The listing of Farminveste highlights the ambition of the company and its long-term objectives, enhancing its domestic and international profile and reputation. It also demonstrates the core mission of Euronext to finance the real economy, giving companies the visibility and the access to a wide range of investors, and also access to capital.

Paulo Jorge Cleto Duarte, CEO of Farminveste, said: “The admission to trading of Farminveste B shares on the Euronext Access platform is a significant step towards the consolidation of the Farminveste group's growth. Its main objective is to enable investors to have a mechanism that facilitates the transaction of the company's shares and the establishment of a reference price for them. It is also an additional guarantor of credibility and transparency for the market."

Farminveste (ticker symbol: MLFMV) was listed through the admission to trading of 9,500,000 B-shares through a technical listing on 16 October 2018The company’s market capitalisation on the day of its listing was €53 million considering only the listed B-shares.

Euronext Access is a gateway market for companies seeking simplified access to listing and improved visibility. It is open to companies of all sizes, maturities or industries.

About Farminveste
Farminveste – Investimentos, Participações e Gestão, S.A. ("Farminveste") is an investment company whose corporate object is to invest in companies in the areas of pharmaceutical distribution, information technology and systems, pharmaceutical market intelligence, provision of healthcare services and real estate. It is owned by the Portuguese National Pharmacies Association whose membership comprisesalmost all pharmacies in Portugal. For more information please visit:

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €6.5 trillion in market capitalisation as of end June 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter ( and LinkedIn (

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at

© 2023, Euronext N.V. - All rights reserved.